Tissue Microarrays for Translational Research
- 974 Downloads
Advances in the identification of genes and proteins that are connected to human disease have resulted in an enormously increased need for validation studies including large sets of clinically well-defined tissue samples in order to translate basic molecular findings into clinically useful applications. The tissue microarray (TMA) technology combines hundreds of minute tissue samples on a single microscopic slide and overcomes the bottleneck of traditional large section tissue analysis. The array format facilitates linking of pathological and clinical data to the molecular results obtained from TMA studies. Consequently, tissue microarrays have become a standard tool for modern high-throughput tissue analysis. Current techniques and applications of the TMA technology in cancer research are discussed.
KeywordsTissue Microarrays Ki67 Label Index Urinary Bladder Cancer Breast Cancer International Research Group Tissue Spot
- Fleischmann A, Schlomm T, Huland H, Kollermann J, Simon P, Mirlacher M et al (2008) Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients. Clin Cancer Res 14(23):7838–7842PubMedCrossRefGoogle Scholar
- Press MF, Sauter G, Bernstein L, Villalobos IE, Mirlacher M, Zhou JY et al (2005) Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res 11(18):6598–6607PubMedCrossRefGoogle Scholar